Glucagon-like peptide-1 (GLP-1) receptor agonists are a class of medications primarily used to manage type 2 diabetes and, in some formulations, chronic weight management
PLoS One 9(2):e90042
We cannot be certain, however, that the claims in our pending patent applications covering the composition of matter of any of our product candidates will be considered patentable by the USPTO, or by patent offices in foreign jurisdictions, or that the claims in any of our patents that may issue will be considered valid and enforceable by courts in the United States or foreign jurisdictions
Its to improve body composition, protect muscle, support long term metabolic resilience, and feel like your body is working with you again
Much has been made of molecular mimicrythat is, the molecular similarity between a viral component for instance and an endogenous CNS protein leading to mistargeted autoimmunityin the pathogenesis of MS (Lang et al., 2002
This evidence from research demonstrates that blander, low-fat, protein-focused meals before and after GLP-1 injections, alongside vigilant hydration and gradual reintroduction of fibre, are essential for comfort and safety